Philadelphia, PA USA

Our News on Newswise

New Therapeutic Strategy Discovered for Ovarian Cancer


Researchers in the laboratory of Rugang Zhang have discovered a target for ovarian clear cell carcinoma, a very difficult-to-treat form of the disease.
16-Feb-2015 3:00 PM EST

Bypassing Resistance to PI3K Therapy Paves the Way to Novel Anticancer Strategies


A study led by researchers at The Wistar Institute has shown that targeting both PI3K and the mitochondria within these cancer cells can dramatically improve the effectiveness of targeted therapy and significantly reduce the chances of developing...
12-Feb-2015 4:00 PM EST

Inflammation Application: How Tumor-Causing Cells are Recruited in Cancers Linked to Chronic Inflammatory Diseases


Gabrilovich and fellow investigators demonstrated what is happening at a cellular level that allows for chronic inflammation to cause a variety of cancers.
9-Feb-2015 4:00 PM EST

Wistar’s Kazuko Nishikura Receives $300K Grant from Macula Vision Research Foundation for Research into Degenerative Eye Disease


Kazuko Nishikura, Ph.D., receives Macula Vision Research Foundation grant for groundbreaking research to find new treatments for macular degeneration.
3-Feb-2015 10:10 AM EST

The Wistar Institute Welcomes Dustin Shilling and Completes its Technology Development and Commercialization Team


Wistar’s newly-created team of technology development professionals are in place to connect scientists’ research with translational science opportunities to form partnerships that will accelerate groundbreaking discoveries in medicine.
28-Jan-2015 11:00 AM EST

Luis J. Montaner Named Herbert Kean, M.D., Family Professor at the Wistar Institute to Foster HIV Cure Research


Luis J. Montaner—noted HIV/AIDS expert—receives endowed professorship.
12-Jan-2015 12:00 PM EST

The Wistar Institute Promotes Elyse Hoffmann to Director of Donor Relations and Special Events


Elyse Hoffmann promoted to Wistar director of donor relations and special events.
22-Dec-2014 10:00 AM EST

One Common Genetic Variant and the Bacteria Inside Of Us Help Dictate Inflammation, Antitumor Activity, and Outcome in Cancer Patients


New findings show how an inactivating polymorphism in the TLR5 Gene that occurs in more than one out of 15 people, plays important role in progression of luminal breast cancer and ovarian cancer
19-Dec-2014 2:00 PM EST

Our YouTube Videos